Same Drug Class

Methotrexate vs Pembrolizumab

Methotrexate vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Methotrexate and Pembrolizumab.

Mechanism of Action

Methotrexate: Dihydrofolate reductase inhibitor.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Methotrexate — 3-10 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Methotrexate — C20H22N8O5.

Molecular Weight: Methotrexate — 454.4400 g/mol.

Type: Methotrexate — Small molecule; Pembrolizumab — Antibody.